I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 30% ± 8% | |
| fibroblast | 6 studies | 21% ± 7% | |
| epithelial cell | 5 studies | 42% ± 18% | |
| oligodendrocyte | 5 studies | 25% ± 6% | |
| B cell | 4 studies | 26% ± 5% | |
| classical monocyte | 4 studies | 22% ± 7% | |
| basal cell | 4 studies | 25% ± 14% | |
| retina horizontal cell | 4 studies | 19% ± 4% | |
| ciliated cell | 4 studies | 31% ± 13% | |
| macrophage | 4 studies | 21% ± 4% | |
| astrocyte | 4 studies | 26% ± 5% | |
| plasmacytoid dendritic cell | 4 studies | 21% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| conventional dendritic cell | 3 studies | 27% ± 11% | |
| hematopoietic precursor cell | 3 studies | 29% ± 9% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| connective tissue cell | 3 studies | 24% ± 5% | |
| naive B cell | 3 studies | 17% ± 2% | |
| GABAergic neuron | 3 studies | 42% ± 4% | |
| glutamatergic neuron | 3 studies | 54% ± 4% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 5% | |
| dendritic cell | 3 studies | 31% ± 12% | |
| enteroendocrine cell | 3 studies | 25% ± 10% | |
| goblet cell | 3 studies | 26% ± 5% |
